Basiliximab significantly reduces acute rejection in renal transplant patients given triple therapy with azathioprine. [electronic resource]
- Transplantation proceedings
- 1009-10 p. digital
Acute Disease Adolescent Adult Aged Anti-Inflammatory Agents--therapeutic use Antibodies, Monoclonal--therapeutic use Azathioprine--therapeutic use Basiliximab Cyclosporine--therapeutic use Drug Therapy, Combination Female Graft Rejection Humans Immunosuppressive Agents--therapeutic use Infections--etiology Kidney Transplantation--immunology Male Middle Aged Postoperative Complications--etiology Prednisone--therapeutic use Recombinant Fusion Proteins